Market Introduction
HER2 positive breast cancer represents a biologically distinct and clinically aggressive subtype of breast cancer characterized by the overexpression of the human epidermal growth factor receptor 2 (HER2) protein. This overexpression accelerates tumor growth and increases the likelihood of disease progression if left untreated. Over the past two decades, advancements in...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek